3D Ready Organoid
| Cat No. | C-029 |
| Organism | Human |
| Tissue | Cerebral |
| Disease | Normal |
| Growth Properties | Embedded 3D Culture |
| Biosafety Level | 1 |
| Growth conditions | 37℃, 95% Air, 5% CO2 |
| Size/Quantity | 1 |
| Product format | Frozen |
| Shipping Info | Dry Ice |
| Storage conditions | Liquid Nitrogen |
View Product Image
Human iPSC-derived cerebral organoid are differentiated from iPSCs. As three-dimensional in vitro models, cerebral organoids effectively replicate the cellular composition and structural organization of human cerebral cortex layers II to VI. Cerebral organoids primarily express glutamatergic, GABAergic, and dopaminergic neurons within 100 days of differentiation. Cerebral organoids are highly valuable for modeling neurodegenerative processes, including responses to PFF-induced toxicity and can be used in the study of Alzheimer’s disease. Organoids are rigorously tested for mycoplasma, bacteria, fungi/yeast, and verified for identity, genetic stability, and functional performance.
Embedded 3D Culture
All test negative for mycoplasma, bacteria, yeast, and fungi.
For research use only. iPSC-derived organoids are used in various research fields, including disease modeling, drug discovery, gene therapy evaluation, and personalized medicine. They can replicate diverse disease states, providing reliable platforms for studying neurodegenerative diseases, cancer and more. Additionally, organoids are valuable for drug efficacy and safety testing, tissue regeneration studies, and exploring host-microbe interactions, advancing innovation in biomedical research.
Whether you're exploring disease mechanisms or screening novel therapeutics, OgCelix is your trusted partner.
Let's build the future of translational research together.
Whether you're exploring disease mechanisms or screening novel therapeutics, OgCelix is your trusted partner.
Let's build the future of translational research together.
